• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人工智能在肺癌临床转化中的进展与挑战

Progress and challenges of artificial intelligence in lung cancer clinical translation.

作者信息

Zhu Erjia, Muneer Amgad, Zhang Jianjun, Xia Yang, Li Xiaomeng, Zhou Caicun, Heymach John V, Wu Jia, Le Xiuning

机构信息

Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Department of Imaging Physics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

出版信息

NPJ Precis Oncol. 2025 Jul 1;9(1):210. doi: 10.1038/s41698-025-00986-7.

DOI:10.1038/s41698-025-00986-7
PMID:40595378
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12214742/
Abstract

Artificial intelligence (AI) algorithms, such as convolutional neural networks and transformers, have significantly impacted cancer care. For lung cancer, AI holds great potential in addressing smoking cessation, personalized screening, and imaging genomics. And these data could be incorporated to optimize treatment selection. This review highlights the transformative impact of AI in lung cancer management, discusses crucial barriers such as model bias and fairness, and outlines future directions for clinical application.

摘要

人工智能(AI)算法,如卷积神经网络和变换器,对癌症治疗产生了重大影响。对于肺癌,人工智能在戒烟、个性化筛查和影像基因组学方面具有巨大潜力。这些数据可用于优化治疗选择。本综述强调了人工智能在肺癌管理中的变革性影响,讨论了模型偏差和公平性等关键障碍,并概述了临床应用的未来方向。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3bd/12214742/c6bc06fee62f/41698_2025_986_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3bd/12214742/c6bc06fee62f/41698_2025_986_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3bd/12214742/c6bc06fee62f/41698_2025_986_Fig1_HTML.jpg

相似文献

1
Progress and challenges of artificial intelligence in lung cancer clinical translation.人工智能在肺癌临床转化中的进展与挑战
NPJ Precis Oncol. 2025 Jul 1;9(1):210. doi: 10.1038/s41698-025-00986-7.
2
Advancements in AI for Computational Biology and Bioinformatics: A Comprehensive Review.用于计算生物学和生物信息学的人工智能进展:全面综述。
Methods Mol Biol. 2025;2952:87-105. doi: 10.1007/978-1-0716-4690-8_6.
3
Artificial intelligence in the management of patient-ventilator asynchronies: A scoping review.人工智能在患者-呼吸机不同步管理中的应用:一项范围综述。
Heart Lung. 2025 Sep-Oct;73:139-152. doi: 10.1016/j.hrtlng.2025.05.003. Epub 2025 May 23.
4
Enhancing ultrasonographic detection of hepatocellular carcinoma with artificial intelligence: current applications, challenges and future directions.利用人工智能增强肝细胞癌的超声检测:当前应用、挑战与未来方向。
BMJ Open Gastroenterol. 2025 Jul 1;12(1):e001832. doi: 10.1136/bmjgast-2025-001832.
5
Research status, hotspots and perspectives of artificial intelligence applied to pain management: a bibliometric and visual analysis.人工智能应用于疼痛管理的研究现状、热点与展望:一项文献计量学与可视化分析
Updates Surg. 2025 Jun 28. doi: 10.1007/s13304-025-02296-w.
6
The Use of AI for Phenotype-Genotype Mapping.人工智能在表型-基因型映射中的应用。
Methods Mol Biol. 2025;2952:369-410. doi: 10.1007/978-1-0716-4690-8_21.
7
Advancements in Herpes Zoster Diagnosis, Treatment, and Management: Systematic Review of Artificial Intelligence Applications.带状疱疹诊断、治疗与管理的进展:人工智能应用的系统评价
J Med Internet Res. 2025 Jun 30;27:e71970. doi: 10.2196/71970.
8
AI in Medical Questionnaires: Innovations, Diagnosis, and Implications.医学问卷中的人工智能:创新、诊断及影响
J Med Internet Res. 2025 Jun 23;27:e72398. doi: 10.2196/72398.
9
The Past, Present, and Future Role of Artificial Intelligence in Ventilation/Perfusion Scintigraphy: A Systematic Review.人工智能在通气/灌注闪烁显像中的过去、现在和未来作用:系统评价。
Semin Nucl Med. 2023 Nov;53(6):752-765. doi: 10.1053/j.semnuclmed.2023.03.002. Epub 2023 Apr 18.
10
Artificial intelligence for detecting keratoconus.人工智能在圆锥角膜检测中的应用。
Cochrane Database Syst Rev. 2023 Nov 15;11(11):CD014911. doi: 10.1002/14651858.CD014911.pub2.

本文引用的文献

1
Regulation of Health and Health Care Artificial Intelligence.健康与医疗人工智能的监管
JAMA. 2025 May 27;333(20):1769-1770. doi: 10.1001/jama.2025.3308.
2
A systematic review of deep learning in MRI-based cerebral vascular occlusion-based brain diseases.基于磁共振成像的脑血管闭塞性脑病中深度学习的系统评价。
Neuroscience. 2025 Mar 5;568:76-94. doi: 10.1016/j.neuroscience.2025.01.020. Epub 2025 Jan 11.
3
External validation of the performance of commercially available deep-learning-based lung nodule detection on low-dose CT images for lung cancer screening in Japan.
基于深度学习的商用肺癌结节检测在日本低剂量CT图像上用于肺癌筛查的性能外部验证。
Jpn J Radiol. 2025 Apr;43(4):634-640. doi: 10.1007/s11604-024-01704-2. Epub 2024 Nov 30.
4
The role of PM2.5 exposure in lung cancer: mechanisms, genetic factors, and clinical implications.细颗粒物(PM2.5)暴露在肺癌中的作用:机制、遗传因素及临床意义。
EMBO Mol Med. 2025 Jan;17(1):31-40. doi: 10.1038/s44321-024-00175-2. Epub 2024 Nov 22.
5
FDA Perspective on the Regulation of Artificial Intelligence in Health Care and Biomedicine.美国食品药品监督管理局对医疗保健和生物医学领域人工智能监管的看法。
JAMA. 2025 Jan 21;333(3):241-247. doi: 10.1001/jama.2024.21451.
6
A Multicenter Open-Label Randomized Phase II Study of Osimertinib With and Without Ramucirumab in Tyrosine Kinase Inhibitor-Naïve -Mutant Metastatic Non-Small Cell Lung Cancer (RAMOSE trial).一项关于奥希替尼联合或不联合雷莫西尤单抗用于酪氨酸激酶抑制剂初治的EGFR突变转移性非小细胞肺癌的多中心开放标签随机II期研究(RAMOSE试验)。
J Clin Oncol. 2025 Feb;43(4):403-411. doi: 10.1200/JCO.24.00533. Epub 2024 Oct 8.
7
Improving Prediction of Survival and Progression in Metastatic Non-Small Cell Lung Cancer After Immunotherapy Through Machine Learning of Circulating Tumor DNA.通过循环肿瘤 DNA 的机器学习提高免疫治疗后转移性非小细胞肺癌的生存和进展预测。
JCO Precis Oncol. 2024 Jun;8:e2300718. doi: 10.1200/PO.23.00718.
8
A multimodal generative AI copilot for human pathology.用于人体病理学的多模态生成式人工智能副驾。
Nature. 2024 Oct;634(8033):466-473. doi: 10.1038/s41586-024-07618-3. Epub 2024 Jun 12.
9
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.2022 年全球癌症统计数据:全球 185 个国家和地区 36 种癌症的发病率和死亡率全球估计数。
CA Cancer J Clin. 2024 May-Jun;74(3):229-263. doi: 10.3322/caac.21834. Epub 2024 Apr 4.
10
Pack-Year Smoking History: An Inadequate and Biased Measure to Determine Lung Cancer Screening Eligibility.吸烟包年数:一种评估肺癌筛查资格的不充分且有偏差的方法。
J Clin Oncol. 2024 Jun 10;42(17):2026-2037. doi: 10.1200/JCO.23.01780. Epub 2024 Mar 27.